Experienced in Fibrolamellar Carcinoma

Dr. Louis C. Garrot

Hematology | Oncology
790 Church Street Northeast, Suite 335, 
Marietta, GA 
Accepting New Patients
Experienced in Fibrolamellar Carcinoma
790 Church Street Northeast, Suite 335, 
Marietta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Louis Garrot is a Hematologist and an Oncologist in Marietta, Georgia. Dr. Garrot is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Lymphofollicular Hyperplasia, Familial Prostate Cancer, and Familial Pancreatic Cancer. Dr. Garrot is currently accepting new patients.

His clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Louisiana State University School Of Medicine, 1999
Residency
Louisiana State University, Internal Medicine, 2002
Specialties
Hematology
Oncology
Licenses
Internal Medicine in GA
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine - Hematology
American Board Of Internal Medicine - Medical Oncology
Fellowships
Beth Israel Deaconess Medical Center, Medical Oncology, 2007
Hospital Affiliations
Northside Hospital Forsyth
Wellstar Cobb Medical Center
Northside Hospital Cherokee
Wellstar Kennestone Regional Medical Center
Northside Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Georgia Cancer Specialists
790 Church Street Northeast, Suite 335, Marietta, GA 30060

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 3
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
Enrollment Status: Active_not_recruiting
Publish Date: November 07, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Apalutamide
Study Phase: Phase 2
View 2 Less Clinical Trials
Similar Doctors
Distinguished in Fibrolamellar Carcinoma
Dr. Walid L. Shaib
Hematology Oncology | Hematology | Oncology
Distinguished in Fibrolamellar Carcinoma
Dr. Walid L. Shaib
Hematology Oncology | Hematology | Oncology

Wellstar Medical Group LLC

677 Church St Ne, Suite 100p, 
Marietta, GA 
 (18.4 miles away)
470-793-8585
Languages Spoken:
English, Arabic, French, Mandarin, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Walid Shaib is a Hematologist Oncology specialist and a Hematologist in Marietta, Georgia. Dr. Shaib is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Colorectal Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Shaib is currently accepting new patients.

Rajni Sinha
Advanced in Fibrolamellar Carcinoma
Dr. Rajni Sinha
Oncology | Hematology
Advanced in Fibrolamellar Carcinoma
Dr. Rajni Sinha
Oncology | Hematology

Piedmont Cancer Institute, PC

1800 Howell Mill Road Northwest, Suite 800, 
Atlanta, GA 
 (28.6 miles away)
404-350-9853
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rajni Sinha is a Hematologist and an Oncologist in Atlanta, Georgia. Dr. Sinha is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, and Pancreatic Cancer. Dr. Sinha is currently accepting new patients.

Olatunji B. Alese
Advanced in Fibrolamellar Carcinoma
Dr. Olatunji B. Alese
Oncology
Advanced in Fibrolamellar Carcinoma
Dr. Olatunji B. Alese
Oncology

Emory Winship Cancer Institute

1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
 (28.7 miles away)
404-778-1900
Experience:
26+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Olatunji Alese is an Oncologist in Atlanta, Georgia. Dr. Alese has been practicing medicine for over 26 years and is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Neuroendocrine Tumor, Gastrointestinal Stromal Tumor, and Pancreaticoduodenectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Garrot's expertise for a condition
ConditionClose
    View All 54 Advanced Conditions
    View All 136 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile